4.35

10.31% -0.50

Envoy Medical Inc (COCH)

Overview News Price History Discussions Forecast

Envoy Medical Inc stock is currently priced at $4.35, with a 24-hour trading volume of 35,314. It has seen a -10.31% decreased in the last 24 hours and a -20.62% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $4.84 pivot point. If it approaches the $4.36 support level, significant changes may occur.

Previous Close:

$4.85

Open:

$4.69

24h Volume:

35,314

Market Cap:

$85.26M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-16.02%

1M Performance:

-20.62%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$4.35

$5.00

52W Range:

$1.08

$11.46

Envoy Medical Inc Stock (COCH) Company Profile

Name

Envoy Medical Inc

Sector

Healthcare (1213)

Industry

Medical Devices (160)

Phone

651-361-8000

Address

4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

COCH's Discussions on Twitter

Envoy Medical Inc Stock (COCH) Latest News

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

GlobeNewswire Inc.

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire Inc.

Envoy Medical to Participate in the 36th Annual ROTH Conference

GlobeNewswire Inc.

Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial

GlobeNewswire Inc.

Envoy Medical Inc Stock (COCH) Financials Data

There is no financial data for Envoy Medical Inc (COCH). Check out other stocks for more information.

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.